---
title: Real-world EGFR testing practices for non-small-cell lung cancer by thoracic
  pathology laboratories across Europe
date: '2023-09-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37713929/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230916180929&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: These results highlight the strong heterogeneity of EGFR
  testing that still occurs within thoracic pathology and molecular biology laboratories
  across Europe. Even among expert testing facilities there is variability in testing
  capabilities, TAT, reflex testing practice and laboratory accreditation, stressing
  the need to harmonise reimbursement technologies and decision-making algorithms
  in ...'
disable_comments: true
---
CONCLUSIONS: These results highlight the strong heterogeneity of EGFR testing that still occurs within thoracic pathology and molecular biology laboratories across Europe. Even among expert testing facilities there is variability in testing capabilities, TAT, reflex testing practice and laboratory accreditation, stressing the need to harmonise reimbursement technologies and decision-making algorithms in ...